|

Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy

RECRUITINGN/ASponsored by Erasmus Medical Center
Actively Recruiting
PhaseN/A
SponsorErasmus Medical Center
Started2026-07-22
Est. completion2027-12
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted

Summary

This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Locally advanced cervical cancer (FIGO 2018 stage 1B3-IVA) with indication for primary radiotherapy including brachytherapy
* Written informed consent

Exclusion Criteria:

* Unable to give informed consent;
* Tumour extension in the lower 2/3rd of the vagina;
* Requiring a Geneva tandem with ovoids' size 13 mm in the first application for brachytherapy;
* Known nylon allergy.

Conditions3

CancerLocally Advanced Cervical CancerUterine Carcinoma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.